Omnicell, Inc. (OMCL) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Omnicell’s revenue went from $696M in fiscal 2016 to $1.2B in fiscal 2025, growth of about 6.1% a year.
Net income in fiscal 2025 was $2M, a net margin of 0.2%; the best year in this period was 2021 with $78M.
Over the twelve months to September 30, 2026, revenue was $1.2B and net income $45M.
Free cash flow was $87M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 26% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.1B | $1.3B | $1.1B | $892M | $897M | $787M | $713M | $696M |
| Gross profit | $561M | $503M | $471M | $497M | $589M | $555M | $413M | $437M | $372M | $319M | $317M |
| Operating income | $65M | $5M | $337000 | -$35M | -$2M | $90M | $36M | $78M | $44M | $11M | $21M |
| Net income | $45M | $2M | $13M | -$20M | $6M | $78M | $32M | $61M | $38M | $31M | $10M |
| EPS (diluted) | $0.96 | $0.04 | $0.27 | $-0.45 | $0.12 | $1.62 | $0.74 | $1.43 | $0.93 | $0.79 | $0.26 |
| R&D | $87M | $89M | $90M | $97M | $105M | $76M | $70M | $69M | $65M | $66M | $58M |
| Revenue growth | — | +6.5% | −3.0% | −11.5% | +14.5% | +26.9% | −0.5% | +13.9% | +10.5% | +2.4% | +43.6% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $186M | $127M | $188M | $181M | $78M | $232M | $186M | $145M | $104M | $25M | $50M |
| Capital spending | -$40M | -$40M | -$36M | -$41M | -$48M | -$29M | -$23M | -$16M | -$24M | -$15M | -$13M |
| Free cash flow | $146M | $87M | $151M | $140M | $30M | $203M | $163M | $129M | $80M | $9M | $36M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $0 | $78M | $0 | $0 | $52M | $0 | $53M | $0 | $0 | $0 | $0 |
| Stock-based pay | $45M | $45M | $39M | $55M | $68M | $53M | $45M | $34M | $29M | $22M | $20M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $197M | $369M | $468M | $330M | $349M | $486M | $127M | $67M | $32M | $54M |
| Debt | — | $37M | $216M | $44M | $50M | $541M | $61M | $111M | $210M | $210M | $254M |
| Equity | — | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $968M | $845M | $680M | $554M | $459M |
| Total assets | — | $2.0B | $2.1B | $2.2B | $2.2B | $2.1B | $1.8B | $1.2B | $1.1B | $1.0B | $935M |
| Shares (diluted) | 46M | 46M | 46M | 45M | 46M | 48M | 44M | 43M | 41M | 39M | 37M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.1% | 42.5% | 42.4% | 43.3% | 45.5% | 49.0% | 46.3% | 48.7% | 47.3% | 44.7% | 45.6% |
| Operating margin | 5.2% | 0.4% | 0.0% | -3.0% | -0.2% | 7.9% | 4.0% | 8.7% | 5.6% | 1.6% | 3.1% |
| Net margin | 3.6% | 0.2% | 1.1% | -1.8% | 0.4% | 6.9% | 3.6% | 6.8% | 4.8% | 4.3% | 1.4% |
| FCF margin | 11.7% | 7.3% | 13.6% | 12.2% | 2.3% | 17.9% | 18.3% | 14.4% | 10.2% | 1.3% | 5.2% |
| ROIC | — | 0.3% | 0.0% | -2.2% | -0.2% | 4.2% | 2.7% | 6.8% | 3.9% | 1.1% | 2.3% |
| ROE | — | 0.2% | 1.0% | -1.7% | 0.5% | 6.8% | 3.3% | 7.3% | 5.5% | 5.5% | 2.1% |
Frequently asked questions
What is Omnicell’s annual revenue?
$1.2B in fiscal 2025 and $1.2B over the twelve months to September 30, 2026.
How much profit does Omnicell make?
Net income was $2M in fiscal 2025 (net margin 0.2%).
Is Omnicell’s revenue growing?
Yes: revenue rose 6.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.